File Browser

BRISTOL-MYERS SQUIBB ET AL v. THE MINISTER OF HEALTH ET AL

Summary of T-282-12

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations

Parties and Lawyers:
PartyFirmLawyer
BRISTOL MYERS SQUIBBNorton Rose OrROBINSON, JUDITH
GILEAD SCIENCES INC
GILEAD SCIENCES LLC
MINISTER OF HEALTH (THE)
TEVA CANADA LTD
Intellectual Property:
NameNumber
2512475

Patented Medicine: Emtricitabine-Tenofovir (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Docket Summary (Google Translate to English)

() 2013-07-03 - Ottawa
Letter from Applicant dated 03-JUL-2013 attaching the Notice of Discontinuance and advising that the Applicants have agreed to discontinue these matters (T-9-12 / T-282-12) and that the Respondents have agreed that the discontinuances will be on a without cost basis. received on 03-JUL-2013
(19) 2013-07-03 - Ottawa
Notice of Discontinuance on a without costs basis signed by all parties on behalf of Applicant filed on 03-JUL-2013
() 2013-06-24 - Ottawa
Oral directions received from the presiding judge dated 21-JUN-2013 directing that "The parties are to advise the Court, within 7 days, whether they are available to participate in a Hearing Management Conference in person in Ottawa on 23-AUG-2013, and if not, their mutual dates of availability for a Hearing Management Conference by way of teleconference in August 2013." placed on file on 24-JUN-2013 Confirmed in writing to the party(ies)
() 2013-06-24 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 24-JUN-2013 directing that "...The Court also notes that no Applicants' Record has been filed in T-9-12 and that no Respondent's Record has been filed in T-282-12, and that the time for doing so has expired. The parties are to advise of their intentions regarding these two matters." (preceded by Directions in T-8-12 allowing the parties to file 40-page Memoranda of Fact and Law) placed on file on 24-JUN-2013 Confirmed in writing to the party(ies)
() 2013-06-07 - Montréal
Covering letter from Applicant dated 07-JUN-2013 concerning Doc. Nos. 17 18 placed on file on 07-JUN-2013
(18) 2013-06-07 - Montréal
Sealed envelope pursuant to Confidentiality Order (doc. #16) dated 31-MAY-2013 on behalf of Applicant purporting to contain the Applicant's Record (confidential version) Filed on 07-JUN-2013
(17) 2013-06-07 - Montréal
Record (public version) in 2 volumes (sent to Ottawa; none kept in Montreal) Number of copies received/prepared: 1 on behalf of Applicant filed on 07-JUN-2013
() 2013-06-04 - Montréal
Acknowledgment of Receipt received from Applicant with respect to the return of doc#13, as per Oral directions dated 31-MAY-2013 placed on file on 04-JUN-2013
() 2013-05-29 - Ottawa
Copy of Letter from Norton Rose Fulbright Canada LLP / s.e.n.c.r.l., s.r.l. dated 13-MAY-2013. re: Change of company name. Copy placed on 62 files. placed on file on 29-MAY-2013 Original placed on Court File No. T-2022-89
() 2013-05-31 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Confidentiality Order Doc. 16 and Directions dated 31-MAY-2013 placed on file on 31-MAY-2013
() 2013-05-31 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 31-MAY-2013 directing that "The time within which Teva is to file its Application Record is extended to 5 days from the date of issuance of a Confidentiality Order. The Applicant shall within 5 days of the issuance of a Confidentiality Order, remove from the Court's record the copies of the Record filed on 22-APR-2013, and replace them with copies conforming with the terms of the Confidentiality Order, particularly paragraph 3 thereof." placed on file on 31-MAY-2013 Confirmed in writing to the party(ies)
(16) 2013-05-31 - Ottawa
Confidentiality Order dated 31-MAY-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent Teva Canada Limited dated 31-MAY-2013 Result: granted "...3. Where it is not reasonably practical to segregate Confidential Information from non-confidential information, the parties may file an entire document or volume thereof in a sealed envelope, provided that a public version of the document or volume, from which the Confidential Information has been redacted or removed, is also filed on the public record. ..." Filed on 31-MAY-2013 copies sent to parties entered in J. & O. Book, volume 1194 page(s) 464 - 466 Interlocutory Decision
() 2013-05-30 - Ottawa
Letter from Respondent Teva Canada Limited dated 30-MAY-2013 on behalf of the parties requesting that a Confidentiality Order issue in the form attached... Teva's Memorandum of Fact and Law is due to be served and filed today... Pending the issuance of a Confidentiality Order, Teva respectfully requests that the designated portions of its Memorandum of Fact and Law be maintained under seal (with a public version also to be filed). Further, since the Application Record has already been filed by Gilead, the parties respectfully request leave from the Court to replace the sealing labels currently on file with revised labels once a Confidentiality Order is issued. received on 30-MAY-2013
() 2013-04-22 - Montréal
Covering letter from Applicant dated 22-APR-2013 concerning Doc. Nos. 13 14 15 placed on file on 22-APR-2013
(15) 2013-04-22 - Montréal
Solicitor's certificate of service on behalf of Nisha Anand confirming service of 13 upon Respondent Teva by personal service on 22-APR-2013 filed on 22-APR-2013
(14) 2013-04-22 - Montréal
Solicitor's certificate of service on behalf of Nisha Anand confirming service of 13 upon Respondent Minister by personal service on 22-APR-2013 filed on 22-APR-2013
(13) 2013-04-22 - Montréal
REMOVED Applicant's Record in 2 volumes with confidential pages in envelopes Number of copies received/prepared: 3 on behalf of Applicant (removed from Court record as per direction of May 31, 2013) filed on 22-APR-2013
() 2013-04-08 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 08-APR-2013 directing that "In view of the limited consent of Teva, the deadlines for serving and filing the parties' respective records are extended to 22-APR-2013 and 30-MAY-2013, respectively." placed on file on 08-APR-2013 Confirmed in writing to the party(ies)
() 2013-04-08 - Ottawa
Communication to the Court from the Registry dated 08-APR-2013 re: Letters dated 5-APR-2013
() 2013-04-05 - Ottawa
Letter from Respondent Teva Canada Limited dated 05-APR-2013 in response to the Applicant's letter dated 5-APR-2013, requesting that the deadlines for service and filing of the parties' Application Records in T-280-12 and T-282-12 not be moved to coincide with the deadlines in T-8-12 and T-9-12, for the following reasons... Under the circumstances, Teva is prepared to consent to a two-week extension for each of T-280-12 and T-282-12. Accordingly, the Application Records would be due on 22-APR-2013 and the Responding Records would be due on 30-MAY-2013. received on 05-APR-2013
() 2013-04-05 - Ottawa
Letter from Applicant dated 05-APR-2013 "The deadlines for the Application and Responding Records in Court File No. T-8-12 were moved to 28-JUN-2013 and 9-AUG-2013 respectively at the request of the parties. These deadlines in Court File No. T-9-12 were moved to 28-MAY-2013 and 9-JUL-2013 respectively. However, through inadvertence, the deadlines for the service and filing of the Application and Responding Records in Court File Nos. T-280-12 and T-282-12 were not moved and remain 8-APR-2013 and 16-MAY-2013 respectively. We therefore propose that the Court move the deadlines to serve and file the Application and Responding Records (in Court File Nos. T-280-12 and T-282-12) to 28-MAY-2013 and 9-JUL-2013 respectively, the dates set down for the service and filing of the records in Court File No. T-9-12. The same patents are being addressed in these two sets of proceedings and the validity of the relevant patents is to be determined in Court File Nos. T-8-12 and T-9-12 and applied to Court File Nos. T-280-12 and T-282-12 (the latter two proceedings will be limited to a determination of infringement only). Furthermore, all four proceedings are to be heard by the same judge during the same 6 day period set down for hearing (September 9 to 16, 2013). The requested extension would allow the parties to focus on completing the cross examinations in T-8-12 and T-9-12." received on 05-APR-2013
() 2012-10-09 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 09-OCT-2012 directing that "The case management telephone conference scheduled for 3:00 p.m. today is cancelled." placed on file on 09-OCT-2012 Confirmed in writing to the party(ies)
() 2012-10-09 - Ottawa
Letter from Applicant dated 09-OCT-2012 advising that the Applicants will not be seeking leave to deliver reply evidence, therefore the case management conference scheduled to be held at 3:00 p.m. today is not necessary. received on 09-OCT-2012
() 2012-09-12 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 12-SEP-2012 directing that "A case management telephone conference will be held at 3:00 p.m. on 9-OCT-2012. The Minister of Health is not required to participate." placed on file on 12-SEP-2012 Confirmed in writing to the party(ies)
() 2012-09-10 - Ottawa
Memorandum to file from CMT Ottawa dated 10-SEP-2012 re: counsel for the Respondent Minister of Health clarified that they do no need to participate in the case management conference unless the Court requests them to. placed on file.
() 2012-09-07 - Ottawa
Letter from Applicant dated 07-SEP-2012 in response to the Directions dated 6-SEP-2012; providing the availability of the Applicants and of the Respondent Teva Canada Limited for a case management conference received on 07-SEP-2012
() 2012-09-07 - Ottawa
Letter from Respondent Minister of Health dated 07-SEP-2012 in response to the Directions dated 6-SEP-2012; providing their availability for a case management conference received on 07-SEP-2012
() 2012-09-06 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 06-SEP-2012 directing that "The Court is not available on the dates suggested. The Court would be available on September 24, September 25 (p.m.), September 26, October 9 (p.m.), or October 11 (p.m.). Parties are requested to advise of their availability as soon as possible." placed on file on 06-SEP-2012 Confirmed in writing to the party(ies)
() 2012-09-05 - Ottawa
Communication to the Court from the Registry dated 05-SEP-2012 re: letter dated 4-SEP-2012
() 2012-09-04 - Ottawa
Letter from Applicant dated 04-SEP-2012 in accordance with paragraph 4 of the Order dated 9-MAY-2012; providing the parties' dates of availability for a case management conference received on 04-SEP-2012
(12) 2012-08-28 - Ottawa
Protective Order dated 28-AUG-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent Teva Canada Limited dated 20-AUG-2012 Result: granted Filed on 28-AUG-2012 copies sent to parties entered in J. & O. Book, volume 1167 page(s) 22 - 30 Interlocutory Decision
() 2012-08-21 - Ottawa
Communication to the Court from the Registry dated 21-AUG-2012 re: Letter dated 20-AUG-2012
() 2012-08-21 - Ottawa
Letter from Respondent Teva Canada Limited dated 20-AUG-2012 submitting a draft protective order on consent of all parties received on 21-AUG-2012
(11) 2012-07-04 - Montréal
Solicitor's certificate of service on behalf of Brian Daley confirming service of Affidavit of Denise Pope and Affidavit of Maria Rossin upon Respondent by hand on 04-JUL-2012 filed on 04-JUL-2012
() 2012-06-01 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 10). placed on file on 01-JUN-2012
(10) 2012-06-01 - Ottawa
Order (time and place) dated 31-MAY-2012 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Montréal on 09-SEP-2013 to begin at 09:30 duration: 6d language: E Filed on 01-JUN-2012 cc's sent to parties entered in J. & O. Book, volume 1159 page(s) 245 - 245 Transmittal letters placed on file
() 2012-05-24 - Ottawa
Communication to the Court from the Registry dated 24-MAY-2012 re: Sent to JA's office for a hearing date to be set down.
() 2012-05-22 - Ottawa
Covering letter from Applicant dated 18-MAY-2012 concerning Doc. Nos. 8 9 placed on file on 22-MAY-2012
(9) 2012-05-22 - Ottawa
Solicitor's certificate of service on behalf of Brian John Capogrosso confirming service of Doc. 8 upon all parties by telecopier on 18-MAY-2012 filed on 22-MAY-2012
(8) 2012-05-22 - Ottawa
Requisition for hearing - Application from Applicant filed on 22-MAY-2012 Tariff Application or appeal - $50.00
() 2012-05-10 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Order Doc. 7 placed on file on 10-MAY-2012
(7) 2012-05-10 - Ottawa
Order dated 09-MAY-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 19-APR-2012 re: proposed schedule, and further to discussions at case management conference held 7-MAY-2012 Result: "1. The parties shall serve and file, no later than 10 days from the date of this Order, a Requisition for Hearing requesting that this matter proceed to a hearing before the same Judge and either concurrently or immediately before or immediately after the hearings in Court files T-8-12, T-9-12 and T-280-12, with an additional day of hearing being added to the 5 days already scheduled for the hearing of files T-8-12 and T-9-12, to accommodate the hearing of T-280-12 and T-282-12. 2. The Applicants' evidence on infringement shall be served no later than 4-JUL-2012. 3. The Respondent, Teva Canada Limited's responding evidence on infringement shall be served no later than 17-SEP-2012. 4. The parties shall, by 4-SEP-2012, provide their mutual dates of availability to participate in a case management telephone conference, to be held within 3 weeks following service of Teva's evidence, to discuss the necessity and timing of any Motion by the Applicants for reply evidence. 5. Cross-examinations shall be completed by the earlier of 4 months from the filing of all reply evidence and January 24, 2013. 6. The Applicants' Record shall be served and filed no later than 8-APR-2013. 7. The Respondent's Record shall be served and filed no later than 16-MAY-2013." Filed on 10-MAY-2012 copies sent to parties entered in J. & O. Book, volume 1156 page(s) 439 - 440 Interlocutory Decision
() 2012-05-07 - Ottawa
Ottawa 07-MAY-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to issue held in chambers by way of Conference Call Duration per day: 07-MAY-2012 from 10:05 to 10:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 10min Appearances: Brian Daley and Brian John Capogrosso (514)847-4764 representing Applicant Jonathan Stainsby and Bill Mayo (416) 360-3568 representing Respondent Teva Canada Limited * no one appearing * representing Respondent Minister of Health Comments: The Court will consult with the judicial administrator's office as to the possibility of having an additional day scheduled in order to have the following Applications heard together: T-8-12, T-9-12, T-280-12 and T-282-12. Scheduling Order to issue endorsing the proposed schedule set out in the Applicants' correspondence dated 19-APR-2012. Heard with T-280-12; Minutes of Hearing taken on that file. Minutes of Hearing entered in Vol. 861 page(s) 449 - 450 Abstract of Hearing placed on file
() 2012-05-01 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 01-MAY-2012 directing that "A case management telephone conference will be held at 10:00 a.m. on 7-MAY-2012." placed on file on 01-MAY-2012 Confirmed in writing to the party(ies)
() 2012-04-23 - Ottawa
Communication to the Court from the Registry dated 23-APR-2012 re: Letter dated 19-APR-2012
() 2012-04-19 - Ottawa
Letter from Applicant dated 19-APR-2012 with the agreement of the Respondent Teva Canada Limited; responding to the Directions dated 19-MAR-2012 received on 19-APR-2012
() 2012-03-20 - Ottawa
Written directions received from the Court: Mireille Tabib, Prothonotary dated 19-MAR-2012 directing that The parties shall, by April 19, 2012, either jointly or seperately, file written submissions as to the following matters and issues: a) Whether any motion pursuant to Section 6(7) of the PM(NOC) Regs is contemplated, and if so, a proposed scheduled for filing parties' respective motion materials. b) Whether any motion for a Confidentiality Order is contemplated, and if so a proposed schedule for filing the parties' respective motion materials. c) Whether any motion pursuant to s. 6(5)(a) or (b) of the PM(NOC) Regs. is contemplated, and if so, the timeframe for bringing such motion. d) A proposed schedule for further steps to be taken...e) Both counsel's joint availabilities to participate in a case managment telephone conference to discuss proposals, issues or matters listed above. placed on file on 20-MAR-2012 Confirmed in writing to the party(ies)
() 2012-03-06 - Ottawa
Communication to the Court from the Registry dated 06-MAR-2012 re: Newly Case Managed File; Requires schedule
() 2012-03-01 - Ottawa
Proof of Service of Fax received from All parties with respect to Doc. #6 (Order from CJC dated Fenruary 29, 2012). placed on file on 01-MAR-2012
(6) 2012-02-29 - Ottawa
Order dated 29-FEB-2012 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Status Review Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 29-FEB-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1150 page(s) 236 - 236 Interlocutory Decision
(5) 2012-02-10 - Montréal
Notice of appearance on behalf of Respondent (The Minister of health) with proof of service upon Applicants on 10-FEB-2012 and on Respondent (Teva) on 10-FEB-2012 filed on 10-FEB-2012
() 2012-02-09 - Montréal
Letter from the Applicants to the Administrator dated 09-FEB-2012 to request an assignment of a Case management Judge in files T-280-12 and T-282-12 since matters are parallel applications to T-8-12 and T-9-12 under section 6 of the Patented Medicines Regulations (Notice of Compliance) which involves common parties and same patents Letter received on 09-FEB-2012
(4) 2012-02-08 - Toronto
Solicitor's certificate of service on behalf of Lesley Caswell confirming service of doc 3 upon all parties by telecopier on 08-FEB-2012 filed on 08-FEB-2012
(3) 2012-02-08 - Toronto
Notice of appearance on behalf of Respondent (Teva) filed on 08-FEB-2012
(2) 2012-02-06 - Toronto
Affidavit of service of Frank Temprile sworn on 06-FEB-2012 on behalf of Applicant confirming service of doc.1 upon respondent Teva Canada by personal service on 03-FEB-2012 filed on 06-FEB-2012
(1) 2012-02-03 - Montréal
Notice of application and 2 copies with regard to Judicial Review (s.18) filed on 03-FEB-2012 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property